Literature DB >> 23411504

Mini-extracorporeal circulation minimizes coagulation abnormalities and ameliorates pulmonary outcome in coronary artery bypass grafting surgery.

J Zeitani1, F Buccisano, S Nardella, M Flaminio, P Prati, G Chiariello, A Venditti, L Chiariello.   

Abstract

Hemostasis is impaired during CABG and coagulation abnormalities often result in clinically relevant organ dysfunctions, eventually increasing morbidity and mortality rates. Fifteen consecutive patients with coronary artery disease submitted to conventional extracorporeal circulation (cECC) have been compared with 15 matched patients, using mini-ECC (MECC). Postoperative lung function was evaluated according to gas exchange, intubation time and lung injury score. In the MECC group, thrombin-antithrombin complex levels (TaTc), prothrombin fragments (PF1+2) formation and thromboelastography (TEG) clotting times were lower compared to the cECC group (p=0.002 and p<0.001, respectively) whereas postoperative blood loss was higher in the cECC group (p=0.030) and more patients required blood transfusion (p=0.020). In the MECC group, postoperative gas exchange values were better, intubation time shorter and lung injury score lower (p<0.001 for all comparisons). Our study suggests that MECC induces less coagulation disorders, leading to lower postoperative blood loss and better postoperative lung function. This approach may be advantageous in high-risk patients.

Entities:  

Keywords:  coronary artery bypass graft surgery; inflammatory response; minimal extracorporeal circulation; thromboelastography

Mesh:

Year:  2013        PMID: 23411504     DOI: 10.1177/0267659113478322

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  2 in total

1.  Impact of minimally invasive extracorporeal circulation on coagulation-a randomized trial.

Authors:  Ivy Susanne Modrau; Debbie Richards Halle; Per Hostrup Nielsen; Hans Henrik Kimose; Jacob Raben Greisen; Michael Kremke; Anne-Mette Hvas
Journal:  Eur J Cardiothorac Surg       Date:  2020-06-01       Impact factor: 4.191

Review 2.  Pulmonary Protection Strategies in Cardiac Surgery: Are We Making Any Progress?

Authors:  Emad Al Jaaly; Mustafa Zakkar; Francesca Fiorentino; Gianni D Angelini
Journal:  Oxid Med Cell Longev       Date:  2015-10-20       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.